Medtronic Recalls Insulin Equipment

Medtronic Corp. is voluntarily recalling its Lot 8 Quick-set insulin infusion equipment used in conjunction with insulin pumps because it may transmit too much or too little insulin to diabetes patients. Diabetics using the equipment have been warned to immediately stop using such equipment. The affected lots include reference numbers MMT-396, MMT-397, MMT-398 and MMT-399, with lot numbers that begin with 8.
According to Medtronic, the recall affects approximately 60,000 units of the insulin equipment. The infusion set is a thin piece of plastic tubing that is replaced every three days. The tubing connects the insulin pump to the patient. While there are no reports of injuries, the medical device malfunction could lead to serious injury or death.
Medtronic Corporation is no stranger to faulty medical device that require recalls. Just last month, the FDA ordered a Class I recall of certain Medtronic Kappa and Sigma pacemakers. These devices may fail due to a separation of wires that connect the electronic circuit to other pacemaker components, such as the battery. A few years ago, Medtronic suspended sales of its Sprint Fidelis defibrillator leads for similar issues.